Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide
Chinese Chemical Letters · 2023-04 · 34 (4) · 107943
DOI: 10.1016/j.cclet.2022.107943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2023-04. Verfasst von Jingmei Yuan und 7 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program, National Natural Science Foundation of China, Sichuan University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Sichuan Province Science and Technology Support Program
- National Natural Science Foundation of China
- Sichuan University
- Science and Technology Planning Project of Shenzhen Municipality
- Science and Technology Bureau of Xinjiang Production and Construction Corps
Zitieren
APA
Yuan, J., Guo, M., Zhao, S., Li, J., Wang, X., Yang, J., Jin, Z., & Song, X. (2023). Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide. Chinese Chemical Letters, 34(4), 107943. https://doi.org/10.1016/j.cclet.2022.107943
Vancouver
Yuan J, Guo M, Zhao S, Li J, Wang X, Yang J, et al. Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide. Chinese Chemical Letters. 2023;34(4):107943. doi:10.1016/j.cclet.2022.107943
BibTeX
@article{Yuan2023,
author = {Yuan, Jingmei and Guo, Mengran and Zhao, Shengnan and Li, Jinhua and Wang, Xinchun and Yang, Jian and Jin, Zhaohui and Song, Xiangrong},
title = {Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide},
journal = {Chinese Chemical Letters},
year = {2023},
volume = {34},
number = {4},
pages = {107943},
doi = {10.1016/j.cclet.2022.107943}
}
EUVIMED